Literature DB >> 6358721

beta-Lactamase inhibitors.

S J Cartwright, S G Waley.   

Abstract

In summary, Table XVI shows the inhibition profiles of representative beta-lactamases from each major class of Richmond and Sykes. Either resistance (R) or sensitivity (S) is given as a general guide to the type of compounds likely to inhibit each class. Thus the (qualitative) statements regarding the effectiveness of clavulanic acid can be taken to represent those for the penam sulfones and similarly for MM4550 and the other olivanic acids, carpetimycins, PS series, and asparenomycins. This can also be said of cloxacillin and the other aromatic carboxamido penicillins. Compounds are also included which are specifically or particularly inhibitory to certain beta-lactamases.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6358721     DOI: 10.1002/med.2610030402

Source DB:  PubMed          Journal:  Med Res Rev        ISSN: 0198-6325            Impact factor:   12.944


  21 in total

1.  In vitro investigation of BK-218, a new oral and parenteral cephalosporin.

Authors:  I Szabó; J Barabás; A Tar; L Kiss; M Filep; T Schmidt; K Marossy; B Tóth-Martinez; G Barabás; F Hernádi
Journal:  Antimicrob Agents Chemother       Date:  1990-02       Impact factor: 5.191

Review 2.  Characterization of beta-lactamases.

Authors:  K Bush
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

Review 3.  Discovery and development of new antimicrobial agents.

Authors:  T D Gootz
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

4.  Inhibition of class C beta-lactamases by (1'R,6R)-6-(1'-hydroxy)benzylpenicillanic acid SS-dioxide.

Authors:  G C Knight; S G Waley
Journal:  Biochem J       Date:  1985-01-15       Impact factor: 3.857

5.  [Clinical significance of beta-lactamase inhibitors].

Authors:  D Adam
Journal:  Klin Wochenschr       Date:  1988-01-15

Review 6.  Methodology for the study of beta-lactamases.

Authors:  K Bush; R B Sykes
Journal:  Antimicrob Agents Chemother       Date:  1986-07       Impact factor: 5.191

7.  Rapid method for determining the beta-lactamase-inducing potency of drugs.

Authors:  H Mett; I Oberkirch; B Schacher
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-10       Impact factor: 3.267

Review 8.  Beta-lactamase inhibitors from laboratory to clinic.

Authors:  K Bush
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

9.  A survey of the kinetic parameters of class C beta-lactamases. Cephalosporins and other beta-lactam compounds.

Authors:  M Galleni; G Amicosante; J M Frère
Journal:  Biochem J       Date:  1988-10-01       Impact factor: 3.857

10.  A survey of the kinetic parameters of class C beta-lactamases. Penicillins.

Authors:  M Galleni; J M Frère
Journal:  Biochem J       Date:  1988-10-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.